Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Patheon Softgels Inc. v. Apotex Inc., 18-0003 (D. Del.) Jan. 2, 2018 Vacant Judgeship (2017) Naproxen Sodium OTC 9,693,978
9,693,979
Jazz Pharms., Inc. v. Mallinckrodt PLC, 18-0029 (D.N.J.) Jan. 2, 2018 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 7,668,730
7,765,106
7,765,107
7,895,059
8,457,988
8,589,182
8,731,963
8,772,306
9,050,302
9,486,426
Bayer Healthcare Pharms. Inc. v. Teva Pharms. USA, Inc., 18-0013 (D. Del.) Jan. 3, 2018 Vacant Judgeship (2017) Finacea® (azelaic acid foam) 7,700,076
8,435,498
8,722,021
8,900,554
9,211,259
9,265,725
Purdue Pharma L.P. v. Amneal Pharms., LLC, 18-0051 (D. Del.) Jan. 3, 2018 Hon. Richard G. Andrews OxyContin® (oxycodone HCl extended-release tablets) 9,770,416
9,775,808
Purdue Pharma L.P. v. Kashiv Pharma, LLC, 18-0052 (D. Del.) Jan. 3, 2018 Hon. Richard G. Andrews OxyContin® (oxycodone HCl extended-release tablets) 9,763,933
9,770,416
9,775,808
Takeda Pharm. Co. Ltd. v. Indoco Remedies Ltd., 18-0055 (D.N.J.) Jan. 3, 2018 Hon. Stanley R. Chesler Kazano® (alogliptin benzoate / metformin HCl tablets) 7,807,689
8,173,663
8,288,539
8,900,638
Eli Lilly and Co. v. Lupin Ltd., 18-0055 (D. Del.) Jan. 4, 2018 Vacant Judgeship (2017) Cialis® (tadalafil tablets) 6,943,166
Argentum Pharms. LLC v. Merck Patentgesellschaft, IPR2018-00423 (PTAB) Jan. 5, 2018 N/A Viibryd® (vilazodone HCl tablets) 8,673,921
Adverio Pharma GMBH v. Alembic Pharms. Ltd., 18-0073 (D. Del.) Jan. 9, 2018 Hon. Leonard P. Stark Adempas® (riociguat tablets) 6,743,798
Mitsubishi Tanabe Pharma Corp. v. Lupin Ltd., 18-0292 (D.N.J.) Jan. 9, 2018 Hon. Peter G. Sheridan Invokana® (canagliflozin tablets)

Invokamet® (canagliflozin / metformin HCl tablets)
7,943,582
8,513,202
Purdue Pharma L.P. v. Ascent Pharms., Inc., 18-0083 (D. Del.) Jan. 11, 2018 Hon. Richard G. Andrews OxyContin® (oxycodone HCl extended-release tablets) 9,060,976
9,073,933
9,522,919
9,149,533
  9,861,582 
  8,309,060 
9,675,610
Celgene Corp. v. Apotex Inc., 18-0461 (D.N.J.) Jan. 11, 2018 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules) 6,315,720
6,561,977
6,755,784
8,315,886
8,626,531
7,465,800
7,855,217
7,468,363
8,741,929
Purdue Pharma L.P. v. Ascent Pharms., Inc., 18-0196 (E.D.N.Y.) Jan. 11, 2018 Hon. William F. Kuntz, II OxyContin® (oxycodone HCl extended-release tablets) 9,060,976
9,073,933
9,522,919
9,149,533
9,861,582
8,309,060
9,675,610
West-ward Pharms. Corp. v. Granules Pharms., Inc., 18-0085 (D. Del.) Jan. 12, 2018 Vacant Judgeship (2017) Mitigare® (colchicine capsules) 8,927,607
9,399,036
9,555,029
9,675,613
9,789,108
H. Lundbeck A/S v. Apotex Inc., 18-0088 (D. Del.) Jan. 12, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 8,722,684
8,969,355
9,227,946
H. Lundbeck A/S v. Apotex Inc., 18-0089 (D. Del.) Jan. 12, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 8,722,684
8,969,355
9,227,946
H. Lundbeck A/S v. Lupin Ltd., 18-0090 (D. Del.) Jan. 12, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 8,722,684
8,969,355
9,227,946
H. Lundbeck A/S v. Macleods Pharms. Ltd., 18-0091 (D. Del.) Jan. 12, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 8,722,684
8,969,355
9,227,946
H. Lundbeck A/S v. Unichem Labs., Ltd., 18-0092 (D. Del.) Jan. 12, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 8,722,684
8,969,355
9,227,946
Patheon Softgels Inc. v. Ohm Labs. Inc., 18-0486 (D.N.J.) Jan. 12, 2018 Hon. Michael A. Shipp Naproxen Sodium OTC 9,693,978
Lupin Ltd. v. Horizon Therapeutics, LLC, IPR2018-00459 (PTAB) Jan. 12, 2018 N/A Ravicti® (glycerol phenylbutyrate oral liquid) 9,561,197
Catalent Pharma Solutions, Inc. v. Patheon Softgels Inc., IPR2018-00421 (PTAB) Jan. 14, 2018 N/A Naproxen Sodium OTC 9,693,978
Catalent Pharma Solutions, Inc. v. Patheon Softgels Inc., IPR2018-00422 (PTAB) Jan. 14, 2018 N/A Naproxen Sodium OTC 9,693,979
Merck Sharp & Dohme Corp. v. MSN Labs. Private Ltd., 18-0675 (D.N.J.) Jan. 16, 2018 Hon. Peter G. Sheridan Emend® (fosaprepitant dimeglumine for injection) 5,691,336
Takeda Pharms. U.S.A., Inc. v. Dr. Reddy’s Labs., Ltd., 18-0101 (D. Del.) Jan. 17, 2018 Hon. Richard G. Andrews Colcrys® (colchicine tablets) 7,906,519
7,935,731
8,093,298
7,964,648
8,093,297
7,619,004
7,601,758
7,820,681
7,915,269
7,964,647
7,981,938
8,093,296
8,097,655
8,415,395
8,415,396
8,440,721
8,440,722
Janssen Pharms., Inc. v. Teva Pharms. USA, Inc., 18-0734 (D.N.J.) Jan. 17, 2018 Hon. John Michael Vazquez Sustenna® (paliperidone palmitate extended-release injectable suspension) 9,439,906
West-ward Pharms. Int’l Ltd. v. Novartis Pharms. Corp., IPR2018-00507 (PTAB) Jan. 17, 2018 N/A Afinitor® (everolimus tablets) 8,410,131
Adverio Pharma GMBH v. MSN Labs. Private Ltd., 18-0111 (D. Del.) Jan. 19, 2018 Hon. Leonard P. Stark Adempas® (riociguat tablets) 7,173,037
Adverio Pharma GMBH v. Teva Pharms USA, Inc., 18-0112 (D. Del.) Jan. 19, 2018 Hon. Leonard P. Stark Adempas® (riociguat tablets) 7,173,037
H. Lundbeck A/S v. Alembic Pharms. Ltd., 18-0113 (D. Del.) Jan. 19, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 8,722,684
8,969,355
9,227,946
H. Lundbeck A/S v. MSN Private Labs. Ltd., 18-0114 (D. Del.) Jan. 19, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 8,722,684
8,969,355
9,227,946
Bristol-Myers Squibb Co. v. Dr. Reddy’s Labs., Ltd., 18-0115 (D. Del.) Jan. 19, 2018 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208
Teva Pharms. Int’l GMBH v. Slayback Pharma Ltd. Liability Co., 18-0117 (D. Del.) Jan. 19, 2018 Hon. Gregory M. Sleet Bendeka® (bendamustine HCl for injection) 9,572,887
Allergan Sales, LLC v. Aurobindo Pharma USA, Inc., 18-0118 (D. Del.) Jan. 19, 2018 Hon. Gregory M. Sleet Bystolic® (nebivolol HCl tablets) 6,545,040
Biogen MA Inc. v. Caribe Holdings (Cayman) Co. Ltd., 18-0121 (D. Del.) Jan. 19, 2018 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Onyx Therapeutics, Inc. v. Apotex Inc., 18-0134 (D. Del.) Jan. 24, 2018 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042
7,232,818
7,491,704
7,737,112
8,129,346
8,207,125
8,207,126
8,207,127
8,207,297
Aurobindo Pharma USA Inc. v. Andrx Corp., IPR2018-00530 (PTAB) Jan. 24, 2018 N/A Fortamet® (metformin HCl extended-release tablets)

Actoplus® MET XR (metformin HCl / pioglitazone HCl extended-release tablets)
6,790,459
H. Lundbeck A/S v. Cipla Ltd., 18-0147 (D. Del.) Jan. 25, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 8,722,684
8,969,355
9,227,946
H. Lundbeck A/S v. Prinston Pharm. Inc., 18-0148 (D. Del.) Jan. 25, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 8,722,684
8,969,355
9,227,946
H. Lundbeck A/S v. Torrent Pharms. Ltd., 18-0149 (D. Del.) Jan. 25, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 7,144,884
8,722,684
8,969,355
9,227,946
H. Lundbeck A/S v. Zydus Pharms. (USA) Inc., 18-0150 (D. Del.) Jan. 25, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 7,144,884
8,476,279
8,722,684
8,969,355
9,227,946
H. Lundbeck A/S v. Zydus Pharms. (USA) Inc., 18-1097 (D.N.J.) Jan. 26, 2018 Hon. Freda L. Wolfson Trintellix® (vortioxetine hydrobromide tablets) 7,144,884
8,476,279
8,722,684
8,969,355
9,227,946
Forest Labs. Holdings, Ltd. v. Sandoz Inc., 18-0171 (D. Del.) Jan. 30, 2018 Hon. Richard G. Andrews Linzess® (linaclotide capsules) 9,708,371
H. Lundbeck A/S v. Amneal Pharms. LLC, 18-0175 (D. Del.) Jan. 30, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 7,144,884
8,476,279
8,722,684
8,969,355
9,227,946
H. Lundbeck A/S v. Hetero USA Inc., 18-0176 (D. Del.) Jan. 30, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 8,722,684
8,969,355
9,227,946
9,861,630
H. Lundbeck A/S v. Sandoz Inc., 18-0177 (D. Del.) Jan. 30, 2018 Hon. Leonard P. Stark Trintellix® (vortioxetine hydrobromide tablets) 8,722,684
8,969,355
9,227,946
H. Lundbeck A/S v. Sandoz Inc., 18-1394 (D.N.J.) Jan. 31, 2018 Hon. Freda L. Wolfson Trintellix® (vortioxetine hydrobromide tablets) 8,722,684
8,969,355
9,227,946
Actelion Pharms. Ltd. v. Zydus Pharms. (USA) Inc., 18-1397 (D.N.J.) Jan. 31, 2018 Hon. Freda L. Wolfson Opsumit® (macitentan tablets) 7,094,781
Pfizer Inc. v. Ajanta Pharma Ltd., 18-0188 (D. Del.) Feb. 1, 2018 Hon. Richard G. Andrews Viagra® (sildenafil citrate tablets) 6,469,012
Takeda Pharms. U.S.A., Inc. v. Alkem Labs. Ltd., 18-0189 (D. Del.) Feb. 1, 2018 Hon. Richard G. Andrews Colcrys® (colchicine tablets) 7,906,519
7,935,731
8,093,298
7,964,648
8,093,297
7,619,004
7,601,758
7,820,681
7,915,269
7,964,647
7,981,938
8,093,296
8,097,655
8,415,395
8,415,396
8,440,721
8,440,722
Hospira, Inc. v. Gland Pharma Ltd., 18-0190 (D. Del.) Feb. 1, 2018 Hon. Richard G. Andrews Precedex® (dexmedetomidine HCl for injection) 8,455,527
8,648,106
9,320,712
9,616,049
Hospira, Inc. v. Jiangsu Hengrui Medicine Co., Ltd., 18-0191 (D. Del.) Feb. 1, 2018 Hon. Richard G. Andrews Precedex® (dexmedetomidine HCl for injection) 8,455,527
8,648,106
9,320,712
9,616,049
Pharmacyclics LLC v. Fresenius Kabi USA, LLC, 18-0192 (D. Del.) Feb. 1, 2018 Hon. Gregory M. Sleet Imbruvica® (ibrutinib tablets) 8,008,309
7,514,444
8,697,711
8,735,403
8,957,079
9,181,257
8,754,091
8,497,277
8,952,015
8,476,284
8,754,090
9,296,753
9,725,455
9,540,382
9,713,617
Merck Sharp & Dohme Corp. v. Fresenius Kabi USA, LLC, 18-0196 (D. Del.) Feb. 2, 2018 Hon. Gregory M. Sleet Noxafil® (posaconazole for injection) 9,023,790
9,358,297
Forest Labs. Holdings, Ltd. v. Teva Pharms. USA, Inc., 18-0198 (D. Del.) Feb. 2, 2018 Hon. Richard G. Andrews Linzess® (linaclotide capsules) 7,304,036
7,371,727
7,704,947
7,745,409
8,080,526
8,110,553
8,933,030
9,708,371
Purdue Pharma L.P. v. Collegium NF, LLC, 18-0026 (D. Del.) Feb. 7, 2018 Hon. Gregory M. Sleet Nucynta® IR (tapentadol tablets)

Nucynta® ER (tapentadol extended-release tablets)
9,861,583
9,867,784
9,872,836
Indivior Inc. v. Dr. Reddy’s Labs. S.A., 18-1775 (D.N.J.) Feb. 7, 2018 Hon. Kevin McNulty Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 9,855,221
Indivior Inc. v. Teva Pharms. USA, Inc., 18-1777 (D.N.J.) Feb. 7, 2018 Hon. Kevin McNulty Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 9,855,221
Indivior Inc. v. Par Pharm., Inc., 18-1780 (D.N.J.) Feb. 7, 2018 Hon. Kevin McNulty Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 9,855,221
Indivior Inc. v. Actavis Labs. UT Inc, 18-0124 (D. Utah) Feb. 7, 2018 Hon. Dustin B. Pead Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 9,855,221
Pharmacyclics LLC v. Shilpa Medicare Ltd., 18-0237 (D. Del.) Feb. 9, 2018 Hon. Gregory M. Sleet Imbruvica® (ibrutinib tablets) 9,296,753
9,725,455
8,999,999
9,801,881
9,801,883
Pharmacyclics LLC v. Cipla Ltd., 18-0247 (D. Del.) Feb. 12, 2018 Hon. Gregory M. Sleet Imbruvica® (ibrutinib tablets) 9,296,753
9,725,455
9,540,382
9,713,617
8,754,090
9,125,889
Takeda Pharm. Co. Ltd. v. Zydus Pharms (USA) Inc., 18-1994 (D.N.J.) Feb. 12, 2018 Hon. Freda L. Wolfson Prevacid® SoluTab™ (lansoprazole delayed-release orally-disintegrating tablets) 6,328,994
7,431,942
7,875,292
7,399,485
Amneal Pharms. LLC v. Allergan, Inc., IPR2018-00608 (PTAB) Feb. 12, 2018 N/A Aczone® (dapsone topical gel) 9,161,926
Sumitomo Dainippon Pharma Co., Ltd. v. Amneal Pharms. LLC, 18-0256 (D. Del.) Feb. 13, 2018 Hon. Richard G. Andrews Latuda® (lurasidone HCl tablets) 9,815,827
Sumitomo Dainippon Pharma Co., Ltd. v. Emcure Pharms. Ltd., 18-2065 (D.N.J.) Feb. 13, 2018 Hon. Stanley R. Chesler Latuda® (lurasidone HCl tablets) 9,815,827
Bayer Healthcare Pharms. Inc. v. Perrigo UK Finco Ltd. Partnership, 18-0261 (D. Del.) Feb. 15, 2018 Vacant Judgeship (2017) Finacea® (azelaic acid foam) 7,700,076
8,435,498
8,722,021
8,900,554
9,211,259
9,265,725
Onyx Therapeutics, Inc. v. Berckenridge Pharm., Inc., 18-0262 (D. Del.) Feb. 15, 2018 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042
7,232,818
7,491,704
7,737,112
8,129,346
8,207,125
8,207,126
8,207,127
8,207,297
Sun Pharma Global FZE v. Lupin Ltd., 18-2213 (D.N.J.) Feb. 15, 2018 Hon. Freda L. Wolfson BromSite® (bromfenac ophthalmic solution) 8,778,999
Pharmacyclics LLC v. Zydus Worldwide DMCC., 18-0275 (D. Del.) Feb. 16, 2018 Hon. Gregory M. Sleet Imbruvica® (ibrutinib tablets) 8,008,309
7,514,444
8,697,711
8,735,403
8,957,079
9,181,257
8,754,091
8,497,277
8,952,015
8,476,284
8,754,090
9,296,753
9,725,455
8,999,999
9,125,889
9,801,881
9,801,883
9,814,721
9,795,604
9,713,617
Osmotica Pharm. US LLC v. Adamas Pharms., Inc., 18-0278 (D. Del.) Feb. 16, 2018 Hon. Gregory M. Sleet Osmolex ER® (amantadine HCl tablets) 8,389,578
8,741,343
8,796,337
8,889,740
8,895,614
8,895,615
8,895,616
8,895,617
8,895,618
8,987,333
9,072,697
Bial – Portela & Ca., S.A. v. Torrent Pharms. Ltd., 18-0279 (D. Del.) Feb. 16, 2018 Vacant Judgeship (2017) Aptiom® (eslicarbazepine acetate tablets) 8,372,431
9,206,135
9,566,244
9,643,929
9,750,747
9,763,954
Pfizer Inc. v. Appco Pharma Ltd., 18-2272 (D.N.J.) Feb. 16, 2017 Hon. Brian R. Martinotti Viagra® (sildenafil citrate tablets) 6,469,012
BTG Int’l Ltd. v. MSN Pharms. Inc., 18-2372 (D.N.J.) Feb. 20, 2018 Hon. Kevin McNulty Zytiga® (abiraterone acetate tablets) 8,822,438
Collegium Pharm., Inc. v. Teva Pharms USA, Inc., 18-300 (D. Del.) Feb. 22, 2018 Hon. Leonard P. Stark Xtampza® ER (oxycodone extended-release capsules) 7,399,488
7,771,707
8,449,909
8,557,291
8,758,813
8,840,928
9,044,398
9,248,195
9,592,200
9,682,075
9,737,530
9,763,883
Baxter Healthcare Corp. v. Hospira, Inc., 18-0303 (D. Del.) Feb. 22, 2018 Hon. Richard G. Andrews Precedex® (dexmedetomidine HCl for injection) 6,716,867
8,242,158
8,338,470
8,455,527
Bial – Portela & Ca., S.A. v. Alkem Labs. Ltd., 18-0304 (D. Del.) Feb. 22, 2018 Vacant Judgeship (2017) Aptiom® (eslicarbazepine acetate tablets) 8,372,431
9,206,135
9,566,244
9,643,929
9,750,747
9,763,954
Bial – Portela & Ca., S.A. v. Lupin Ltd., 18-0312 (D. Del.) Feb. 23, 2018 Vacant Judgeship (2017) Aptiom® (eslicarbazepine acetate tablets) 8,372,431
9,206,135
9,566,244
9,643,929
9,750,747
9,763,954
Sumitomo Dainippon Pharma Co., Ltd. v. Aurobindo Pharma Ltd., 18-2620 (D.N.J.) Feb. 23, 2018 Hon. Stanley R. Chesler Latuda® (lurasidone HCl tablets) 9,815,827
Apotex Inc. v. Celgene Corp., IPR2018-00685 (PTAB) Feb. 23, 2018 N/A Revlimid® (lenalidomide capsules) 8,741,929
Kashiv Pharma, LLC v. Purdue Pharma L.P., IPR2018-00625 (PTAB) Feb. 27, 2018 N/A OxyContin® (oxycodone HCl extended-release tablets) 9,492,392
Kashiv Pharma, LLC v. Purdue Pharma L.P., IPR2018-00717 (PTAB) Feb. 28, 2018 N/A OxyContin® (oxycodone HCl extended-release tablets) 9,492,393
Bial – Portela & Ca., S.A. v. Jubilant Life Sciences Ltd., 18-0336 (D. Del.) Mar. 1, 2018 Vacant Judgeship (2017) Aptiom® (eslicarbazepine acetate tablets) 8,372,431
9,206,135
9,566,244
9,643,929
9,750,747
9,763,954
Biogen Int’l GMBH v. MSN Labs. Private Ltd., 18-0337 (D. Del.) Mar. 1, 2018 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376
7,320,999
Fresenius Kabi USA, LLC v. BioQ Pharma Inc., 18-3032 (D.N.J.) Mar. 1, 2018 Hon. Susan D. Wigenton Diprivan® (propofol for injection) 8,476,010
Fresenius Kabi USA, LLC v. BioQ Pharma Inc., 18-1408 (N.D. Cal.) Mar. 2, 2018 Hon. Jeffrey S. White Diprivan® (propofol for injection) 8,476,010
Bial – Portela & Ca., S.A. v. Dr. Reddy’s Labs., Ltd., 18-0341 (D. Del.) Mar. 2, 2018 Vacant Judgeship (2017) Aptiom® (eslicarbazepine acetate tablets) 8,372,431
9,206,135
9,566,244
9,643,929
9,750,747
9,763,954
Bial – Portela & Ca., S.A. v Hetero Labs Ltd., 18-0342 (D. Del.) Mar. 2, 2018 Vacant Judgeship (2017) Aptiom® (eslicarbazepine acetate tablets) 8,372,431
9,206,135
9,566,244
9,643,929
9,750,747
9,763,954
Bial – Portela & Ca., S.A. v. Dr. Reddy’s Labs., Ltd., 18-3098 (D.N.J.) Mar. 2, 2018 Hon. Freda L. Wolfson Aptiom® (eslicarbazepine acetate tablets) 8,372,431
9,206,135
9,566,244
9,643,929
9,750,747
9,763,954
Biogen Int’l GMBH v. Impax Labs., Inc., 18-0350 (D. Del.) Mar. 5, 2018 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 6,509,376
7,320,999
Boehringer Ingelheim Pharms., Inc. v. Fresenius Kabi USA, LLC, 18-3244 (D.N.J.) Mar. 7, 2018 Hon. Michael A. Shipp Gilotrif® (afatinib tablets) RE43,431
8,426,586
Sumitomo Dainippon Pharma Co., Ltd. v. InvaGen Pharms., Inc., 18-1444 (E.D.N.Y.) Mar. 8, 2018 Hon. Pamela K. Chen Latuda® (lurasidone HCl tablets) 9,815,827
Sumitomo Dainippon Pharma Co., Ltd. v. Par Pharm., Inc., 18-2107 (S.D.N.Y.) Mar. 8, 2018 Hon. Ronnie Abrams Latuda® (lurasidone HCl tablets) 9,815,827
Sumitomo Dainippon Pharma Co., Ltd. v. Accord Healthcare, Inc., 18-0185 (M.D.N.C.) Mar. 8, 2018 Hon. Loretta C. Biggs Latuda® (lurasidone HCl tablets) 9,815,827
Sumitomo Dainippon Pharma Co., Ltd. v. First Time US Generics, LLC, 18-0369 (D. Del.) Mar. 8, 2018 Hon. Richard G. Andrews Latuda® (lurasidone HCl tablets) 9,815,827
Pfizer Inc. v. Prinston Pharm. Inc., 18-0380 (D. Del.) Mar. 9, 2018 Hon. Leonard P. Stark Xeljanz® (tofacitinib tablets) RE41,783
Bial – Portela & Ca., S.A. v. Apotex Inc., 18-0382 (D. Del.) Mar. 9, 2018 Vacant Judgeship (2017) Aptiom® (eslicarbazepine acetate tablets) 8,372,431
9,206,135
9,566,244
9,643,929
9,750,747
9,763,954
Vifor Fresenius Medical Care Renal Pharma Ltd. v. Lupin Atlantis Holdings SA, 18-0390 (D. Del.) Mar. 12, 2018 Hon. Leonard P. Stark Velphoro® (sucroferric oxyhydroxide chewable tablets) 6,174,442
9,561,251
Collegium Pharm., Inc. v. Purdue Pharma L.P., PGR2018-00048 (PTAB) Mar. 13, 2018 N/A OxyContin® (oxycodone HCl extended-release tablets) 9,693,961
Leo Pharma A/S v. Perrigo UK Finco Ltd., 18-0401 (D. Del.) Mar. 14, 2018 Hon. Joseph F. Bataillon Picato® (ingenol Mebutate gel) 8,278,292
9,820,959
9,833,428
9,833,429
Leo Pharma A/S v. Actavis Labs. UT, Inc., 18-0402 (D. Del.) Mar. 14, 2018 Hon. Joseph F. Bataillon Picato® (ingenol Mebutate gel) 8,278,292
9,820,959
9,833,428
9,833,429
Purdue Pharma L.P. v. Intellipharmaceutics Int’l Inc., 18-0404 (D. Del.) Mar. 14, 2018 Hon. Richard G. Andrews OxyContin® (oxycodone HCl extended-release tablets) 9,060,976
9,073,933
9,522,919
9,492,389
9,492,391
9,775,808
9,763,886
9,763,933
8,309,060
9,675,610
Gilead Sciences, Inc. v. Natco Pharma Ltd., 18-3592 (D.N.J.) Mar. 14, 2018 Hon. Peter G. Sheridan Sovaldi® (sofosbuvir tablets) 8,618,076
9,284,342
7,429,572
8,415,322
9,206,217
9,340,568
Corcept Therapeutics, Inc. v. Teva Pharms. USA, Inc., 18-3632 (D.N.J.) Mar. 15, 2018 Hon. Susan D. Wigenton Korlym® (mifepristone tablets) 8,921,348
9,829,495
Gilead Sciences, Inc. v. Natco Pharma Ltd., 18-0411 (D. Del.) Mar. 16, 2018 Hon. Leonard P. Stark Sovaldi® (sofosbuvir tablets) 8,618,076
9,284,342
7,429,572
8,415,322
9,206,217
9,340,568
Insys Therapeutics, Inc. v. Teva Pharms. USA, Inc., 18-0414 (D. Del.) Mar. 16, 2018 Hon. Gregory M. Sleet Subsys® (fentanyl sublingual spray) 8,486,972
8,486,973
8,835,459
8,835,460
9,241,935
9,289,387
9,642,797
9,642,844
Merck Sharp & Dohme Corp. v. Mylan Labs. Ltd., 18-0450 (D. Del.) Mar. 23, 2018 Hon. Gregory M. Sleet Noxafil® (posaconazole for injection) 9,023,790
9,358,297
Taro Pharms U.S.A., Inc. v. Lupin Ltd., 18-4225 (D.N.J.) Mar. 23, 2018 Hon. John Michael Vazquez Topicort® (desoximetasone topical spray) 8,277,780
8,715,624
Delcor Asset Corp. v. Glenmark Pharms. Ltd., 18-0460 (D. Del.) Mar. 26, 2018 Vacant Judgeship (2017) Olux-E® (clobetasol propionate aerosol foam) 6,730,288
Gilead Sciences, Inc. v. Teva Pharms. USA, Inc., 18-4273 (D.N.J.) Mar. 26, 2018 Hon. Peter G. Sheridan Sovaldi® (sofosbuvir tablets) 7,964,580
8,334,270
8,580,765
9,085,573
7,429,572
8,415,322
8,633,309
9,284,342
8,618,076
9,549,941
8,889,159
8,629,263
8,735,569
9,637,512
8,642,756
9,206,217
9,340,568
Takeda Pharms. U.S.A., Inc. v. Zydus Pharms. (USA) Inc., 18-0464 (D. Del.) Mar. 27, 2018 Hon. Richard G. Andrews Colcrys® (colchicine tablets) 7,906,519
7,935,731
8,093,298
7,964,648
8,093,297
7,619,004
7,601,758
7,820,681
7,915,269
7,964,647
7,981,938
8,093,296
8,097,655
8,415,395
8,415,396
8,440,721
8,440,722
Gilead Sciences, Inc. v. Teva Pharms. USA, Inc., 18-0466 (D. Del.) Mar. 27, 2018 Unassigned Judge Sovaldi® (sofosbuvir tablets) 7,964,580
8,334,270
8,580,765
9,085,573
7,429,572
8,415,322
8,633,309
9,284,342
8,618,076
9,549,941
8,889,159
8,629,263
8,735,569
9,637,512
8,642,756
9,206,217
9,340,568
Bracco Diagnostics Inc. v. Jubilant Draximage Inc., 18-4422 (D.N.J.) Mar. 27, 2018 Hon. Michael A. Shipp CardioGen-82 (rubidium 82 generator)

Ruby-Fill® (strontium-rubidium radioisotope infusion system)
9,814,826
9,750,869
9,750,870
9,299,467
9,299,468
Takeda Pharms. U.S.A., Inc. v. Zydus Pharms (USA) Inc., 18-4591 (D.N.J.) Mar. 28, 2018 Hon. Michael A. Shipp Colcrys® (colchicine tablets) 7,906,519
7,935,731
8,093,298
7,964,648
8,093,297
7,619,004
7,601,758
7,820,681
7,915,269
7,964,647
7,981,938
8,093,296
8,097,655
8,415,395
8,415,396
8,440,721
8,440,722
Forest Labs. Holdings, Ltd. v. Mylan Pharms. Inc., 18-0482 (D. Del.) Mar. 29, 2018 Unassigned Judge Linzess® (linaclotide capsules) 7,304,036
7,371,727
7,704,947
7,745,409
8,080,526
8,110,553
8,933,030
Merck Sharp & Dohme Corp. v. Mylan Labs. Ltd., 18-1334 (E.D. Pa.) Mar. 29, 2018 Hon. Gene E.K. Pratter Noxafil® (posaconazole for injection) 9,023,790
9,358,297

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.